Evidence for a glucosyl-enzyme intermediate in the beta-glucosidase-catalyzed hydrolysis of p-nitrophenyl-beta-D-glucoside

The reaction of almond β-glucosidase with $\text{p}$-nitrophenyl-β-$\text{D}$-glucoside has been investigated over the temperature range +25° to ?45° using 50% aqueous dimethyl sulfoxide (DMSO) as solvent. At temperatures below those at which turnover occurs a “burst” of $\text{p}$-nitrophenol proportional to the enzyme concentration is observed. Such a “burst” suggests the existence of a glucosyl-enzyme intermediate whose breakdown is rate-limiting, and provides a method for measuring the active-site normality. At pH 5.9, 25°, the presence of 50% DMSO causes an increase in K_m from 1.7×10^?3M (0%) to 1.7×10^?2M, whereas V_max is unchanged. The DMSO thus apparently acts as a competitive inhibitor with K_i = 0.7M. The Arrhenius plot for turnover is linear over the accessible temperature range with E_a = 23.0 ± 2.0 kcal/mole.     

Uncoupling of acetylcholine uptake from the Torpedo cholinergic synaptic vesicle ATPase

Cholinergic synaptic vesicles isolated from the electric organ of $\text{Torpedo californica}$ are confirmed to exhibit energy-linked uptake of [³H] acetylcholine. [³H]Acetylcholine is concentrated in the vesicles by a factor of 10–14 in the presence of MgATP and bicarbonate. This active uptake can be completely inhibited by the mitochondrial uncouplers 3-$\text{t}$-butyl-5-Cl-2′-Cl-4′-nitro-salicylanilide (S-13) and $\text{p}$-nitrophenol. The vesicle-associated ATPase is stimulated by S-13 in the same concentration range which inhibits [³H]acetylcholine active uptake. The ATPase also is stimulated by valinomycin. Both S-13 and valinomycin effects are independent of exogenous Ca²⁺. Thus, a proton gradient generated by the vesicle-associated ATPase appears to be coupled to active [³H]acetylcholine uptake.     

Precocious development in utero of certain UDP-glucuronyltransferase activities in rat fetuses exposed to glucocorticoids.

The first precocious development of UDP glucuronyltransferase in the mammalian fetus $\text{in utero}$ by a known compound of endogenous origin is described. Intraperitoneal injection of cortisol (8 mg) into maternal rats on days 14 and 15 of gestation stimulated fetal-liver transferase activity from near zero to $\text{1}\text{2}$ maternal levels by day 17; 0.3 mg dexamethasone, possessing a longer biological half-life, raised activity to full maternal level by day 16. In controls, injected with solvent only, fetal-liver transferase remained low on day 16. With both glucocorticoids, transferase stimulation was dose-dependent. Transferase activities were assayed in a range of digitonin concentrations from zero to above optimal for enzyme activation. Activities stimulated were towards $\text{o}$-aminophenol, $\text{p}$-nitrophenol, 1-naphthol and serotonin. Activities towards bilirubin, morphine and testosterone were not stimulated. The former group of activities are stimulated by glucocorticoids in culture and normally reach approximate adult levels just before birth; the latter group are not so stimulated on culture and normally reach adult levels after birth. Implications of these findings are discussed.     

The hydroxylation of P-cresol and its conversion to P-hydroxybenzaldehyde in Pseudomonas putida.

Cell extracts of $\text{Pseudomonas putida}$ catalyze the conversion of $\text{p}$-cresol to $\text{p}$-hydroxybenzylalcohol when phenazine methosulfate, an electron acceptor, is added. The reaction will proceed under anaerobic conditions and a mechanism involving dehydrogenation to a heteroquinone followed by hydration is proposed. This contrasts with the known attack on methyl groups by mono-oxygenases. The same requirements are found for the alcohol dehydrogenase and the major product from reaction mixtures is the aldehyde. Of the compounds tested as substrates only those with the appropriate groups in the $\text{para}$ orientation were attacked.     

The involvement of cytochrome P-450 in the NADH-dependent O-demethylation of p-nitroanisole in phenobarbital-treated rabbit liver microsomes.

Addition of $\text{p}$-nitroanisole to a reaction mixture containing phenobarbital-pretreated rabbit liver microsomes brings about an increase the reoxidation rate of NADH-reduced cytochrome b₅. Addition of partially purified cytochrome b₅ to a solution containing microsomes results in a marked increase in both NADH- and NADPH-dependent O-demethylation of $\text{p}$-nitroanisole. $\text{p}$-Nitroanisole also increases the rate of NADH mediated cytochrome P-450 reduction. From these and other results described in the Discussion section, we confirm that electrons required for NADH-dependent O-demethylation of $\text{p}$-nitroanisole is transfered from NADH to cytochrome P-450 via cytochrome b₅ and that cytochrome P-450 is the enzyme which catalyzes $\text{p}$-nitroanisole O-demethylation.     

Release of the chloride-dependent arginine aminopeptidase from PMN leukocytes and macrophaces during phagocytosis

The zymosan particles induced a time-dependent release of the chloride-dependent arginine aminopeptidase from rat peritoneal macrophages during $\text{in}$$\text{vitro}$ incubations. Intraperitoneal injections of zymosan, a streptococcal cell preparation and a $\text{Micrococcu}$-suspension caused the release of the chloride-activated arginine aminopeptidase into the peritoneal fluid. The arginine aminopeptidases obtained both from the cell cultivation media and the peritoneal washes were partly purified. The enzymes were similar with regard to the following properties: chloride activation with an optimum at physiological concentrations; strong inhibition by 10^?6M $\text{p}$-chloromercuribenzoate; similar elution properties and preferential hydrolysis of mainly the $\text{N}$-L-aminoacyl-2-naphthylamines of arginine and lysine. The chloride-activated arginine aminopeptidase released into the media in $\text{in}$$\text{vitro}$ conditions was inactivated in contrast to the enzyme released into the peritoneal fluid as a result of the intraperitoneal injections. The timing of the release of the chloride-activated arginine aminopeptidase both $\text{in}$ and $\text{in}$$\text{vitro}$ suggests that the enzyme plays a role in the initial phases of inflammation.     

Mandelic acid-4-hydroxylase, a new inducible enzyme from Pseudomonas convexa

A soluble fraction of $\text{Pseudomonas convexa}$ catalyzed the hydroxylation of mandelic acid to $\text{p}$-hydroxymandelic acid. The enzyme had a pH optimum of 5.4 and showed an absolute requirement for Fe²⁺, tetrahydropteridine, NADPH. $\text{p}$-Hydroxymandelate, the product of the enzyme reaction was identified by paper chromatography, thin layer chromatography, UV and IR-spectra.     

Effect of bombesin-stimulated gastrin on gastric acid secretion in man

The effect of bombesin on gastrin release and gastric acid secretion was investigated in 10 healthy volunteers. Bombesin (0.6 μg · Kg^?1 · hr^?1) produced a significantly higher $\text{(}\text{p}\text{<}\text{0.001)}$ increase in plasma gastrin levels (86.7 11.1 pmo/1 than after a protein meal (39.6 ± 5.6 pmol1/1). The gastric acid secretory response to bombesin (12.1 ± 2.9 mEq · hr^?1) was however significantly lower $\text{(}\text{p}\text{<}\text{0.005)}$ than the maximal response produced by pentagostrin (20.9 ± 3.5 mEq · hr^?1) at the dose of 6 μg · Kg^?1. Atropine did not modify gastrin release induced by bombesin but significantly reduced gastric acid secretion $\text{(}\text{p}\text{<}\text{0.01)}$. From the data presented it may be hypothesized that less biologically active forms of gastrin and/or other peptides inhibiting the gastrin effect upon gastric acid secretion may be released by bombesin.     

The beta-galactosidase-catalyzed hydrolysis of o-nitrophenol-beta-D-galactoside at subzero temperatures: evidence for a galactosyl-enzyme intermediate.

The reaction of β-galactosidase ($\text{E. coli}$ K12) with $\text{o}$-nitrophenyl-β-$\text{D}$-galactoside has been investigated over the temperature range +25° to ?30° using 50% aqueous dimethyl sulfoxide as solvent. At temperatures below ?10° turnover becomes very slow and a burst of $\text{o}$-nitrophenol is observed. Such a burst indicates the existence of a galactosyl-enzyme intermediate whose breakdown is rate-limiting and provides a means of determining the active site normality. The Arrhenius plot for turnover is linear in the ?25 to +25° range with E_a = 26 ± 3 kcal/mole. The presence of the 50% DMSO had no effect on K_m but caused a small decrease in K_cat.     

Energy transfer and molecular switching II. Muscle contraction and enzymatic reactions

In Part I (Barrett, 1981), the concept of chemical parametric excitation was reviewed and applied to the process of nerve action potential excitation and regeneration. In the present paper, the chemical reactions involved in muscle contraction and the enzymatic reaction are examined and shown to be examples of chemical parametric excitation.It is demonstrated that in a model biochemical scheme for an enzymatic reaction, the enzyme is activated from a state, X, to a state, $\text{X}{}^1$, and in this activated state pumps the reaction parametrically. The concept of enzyme is identified with an excited state or state of disequilibrium permitting a release of energy during the dissipation, $\text{X}{}^1\text{→X}$, in the enzymatic reaction, which is powered by the release of energy in the return to the unexcited state X. The demonstration of parametric excitation relations for chemical systems indicates an explanation for the directionality of energy flow and designates an energy pumping role for an enzyme.In muscle contraction, the role of $\text{X}{}^1$ is played by actomyosin and Ca²⁺, and the enzymatic reaction is the hydrolysis of ATP. The release of energy caused by this hydrolysis reaction brings about the conformational changes underlying muscle contraction.     

Prevention of the hepatotoxic action of N-hydroxy-2-acetylaminofluorene in the rat by inhibition of NO-sulfation by pentachlorophenol

The extent of the hepatotoxic action of $\text{N}$-hydroxy-2-acetylaminofluorene in the rat was determined by following changes in histochemistry, and the activities of glutamate-oxaloacetate transaminase (EC 2.6.1.1) and glutamate-pyruvate transaminase (EC 2.6.1.2) in serum. Administration of $\text{N}$-hydroxy-2-acetylaminofluorene (120 μmol/kg i.v.) cased a periportal (zone I) necrosis which was accompanied by a large increase in glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase activity in serum. Treatment of rats with pentachlorophenol and 2, 6-dichloro-4-nitrophenol, known inhibitors of NO-sulfation, 45 min before the administration of $\text{N}$-hydroxy-2-acetylaminofluorene, completely prevented the hepatotoxic effects of this carcinogenic hydroxamic acid. Therefore, it is concluded that NO-sulfation is responsible for the hepatotoxic action of $\text{N}$-hydroxy-2-acetylaminofluorene.     

Response of the mixed function oxidase system of rat hepatic microsomes to parathion and malathion and their oxygenated analogs

$\text{In}$$\text{vitro}$ inhibition of ethylmorphine metabolism in rat hepatic microsomes by parathion, malathion, malaoxon and paraoxon was not well correlated with their effects on NADPH oxidation, cytochrome C reduction or the reduction of cytochrome P-450. A parallel relationship was observed between inhibition of ethylmorphine metabolism by parathion, malathion and malaoxon and the binding affinity of these agents to microsomal cytochrome P-450 obtained from rats pretreated with an anticholinesterase agent, Bis-[?-nitrophenol] phosphate.     

Synthesis and biological activity of glycosylated analogs of somatostatin

The synthesis by solid-phase methodology of two glycosylated analogs of somatostatin [Glc-Asn⁵]-SS and [NAcGlc-Asn⁵]-SS is described. These two analogs have been biologically tested on the secretion of pituitary growth hormone, pancreatic glucagon and insulin. The results show that glycosylation of somatostatin on the Asn⁵ residue decreases by a hundred fold the inhibition activity on GH release when tested $\text{in}$$\text{vitro}$. $\text{In}$$\text{vivo}$, since the activity is similar to somatostatin the carbohydrates are probably removed by some enzymatic reaction and thus liberate the full activity of somatostatin.     

The p-cymene pathway in PseudomonasputidaPL: Isolation of a dihydrodiol accumulated by a mutant

A mutant strain (PL pT $\text{11}\text{43}$) of $\text{Pseudomonas}\text{putida}$ PL, has been isolated for its inability to growth with $\text{p}$-cymene as carbon source. The mutant oxidizes $\text{p}\text{-cymene}$ (and $\text{p}$-cumate) to a compound (λmax 293 nm) which is readily converted to 3-hydroxy-$\text{p}$-cumate by acid. 4-Trifluoromethylbenzoate is oxidized by the mutant to an acid-stable intermediate (λmax 277nm) that has been crystallized. The spectral properties (u.v., i.r., NMR and mass) of this metabolite are consistent with those expected for a 2,3-dihydro-2,3-dihydroxy derivative of 4-trifluoromethylbenzoate. Further support of this structure was provided by elemental analysis and the properties of two derivatives of the metabolite, 4-trifluoromethyl-3-hydroxybenzoate and an acetonide formed with 2,2-dimethoxypropane. The stability of a product obtained by treatment of the dihydrodiol metabolite with triacetylosmate indicates that it is the $\text{cis}\text{-isomer}$.     

Organophosphorus compounds as active site-directed inhibitors of elastase

Four ethyl $\text{p}$-nitrophenyl alkylphosphonates were studied for the inhibition of elastase. A pH-dependence study using the assay substrate BOC-Ala-ONp or the phosphonate inhibitors showed the participation of an ionizing group with an apparent pK_a of 6.9 and a decrease of reaction or inhibition at higher pH. Out of the four compounds investigated ethyl $\text{p}$-nitrophenyl pentylphosphonate was found to be the best inhibitor of elastase as judged from the value of $\text{k}{}_2\text{K}{}_{\mathrm{<mtext>I</mtext>}}$. This value, which is the measure of inhibitory capacity, is the highest reported so far for the inhibition of elastase.     

Enhanced rates of acyl transfer to a neighboring hydroxyl group

2-Hydroxymethyl-4-nitrophenyl trimethylacetate is rapidly converted, by an intramolecular pathway, to its benzyl ester counterpart in aqueous solutions of dilute buffers. Intramolecular acyl migration is favored by a factor of 10⁵ over intermolecular transfer of the trimethylacetyl group to surrounding water molecules. The activation parameters of the reaction demonstrate that the rate acceleration is primarily entropic in origin. At constant pH, the apparent first-order rate constant for intramolecular acyl migration displays a linear dependence on the concentration of the basic component of the buffer. For catalysis by imidazole, a solvent deuterium isotope effect of $\text{k}{}_{\mathrm{<mtext>H</mtext>}}\text{k}{}_{\mathrm{<mtext>D</mtext>}}\text{= 2.4}$ is observed, in accord with a general base-catalyzed pathway. Similarities between intramolecular and intracomplex transacylations are discussed with the conclusion that the migration of a trimethylacetyl group from the phenolic oxygen atom of a 2-hydroxymethyl-4-nitrophenol to the adjacent benzylic oxygen atom provides an accurate model for acylation of the serine hydroxyl group at the active site of α-chymotrypsin by nitrophenyl esters.     

Further evidence for an active center in streptokinase-plasminogen complex; interaction with pancreatic trypsin inhibitor

Earlier work has shown that streptokinase and human plasminogen form a stoichiometric complex in which the presence of a functional active center can be detected by reaction with the active center-specific reagent, $\text{p}$-nitrophenyl-$\text{p′}$-guanidinobenzoate. The complex possesses activator activity, i.e. it catalyzes the conversion of plasminogen to plasmin. Evidence is presented to show that pancreatic trypsin inhibitor abolishes both the activator activity and the ability to react with the active center-specific reagent. This is accomplished, not by displacement of streptokinase, but by the formation of a ternary complex with streptokinase-plasminogen.     

Aryl alpha-haloalkyl ketoximes as enzyme modifying agents. The reaction of alpha-haloacetophenone oximes with the active site of papain

$\text{Syn}$-α-chloroacetophenone oxime has been found to inactivate papain rapidly at pH 7 and 25.0^O in a 1:1 stoichiometric fashion as measured by rate assays with $\text{p}$-nitrophenyl $\text{N}$-benzyloxycarbonylglycinate and sulfhydryl group titrations with 5,5′-dithiobis-(2-nitrobenzoic acid). By the use of a ¹⁴C label in the halomethyl function a similar stoichiometric reaction with papain could be demonstrated for $\text{syn}$-α-bromoacetophenone oxime despite the rapidity of the competitive nonenzymatic solvolysis of the latter compound under the conditions employed. These results indicate that a new class of reactive modifying agents, α-haloalkyl oximes, can be used for the selective alkylation of catalytically essential functional groups in enzyme active sites.     

Inhibition of surfactant release from isolated type II cells by compound 4880

Release of [³H]phosphatidylcholine from pulmonary Type II epithelial cells was stimulated by terbutaline, forskolin and cytochalasin D. Compound $\text{48}\text{80}$ inhibited both basal and agonist-stimulated release of [³H]PC. The IC₅₀ for inhibition by compound $\text{48}\text{80}$ was 1–2 μg/ml, and was similar for inhibition of both basal and stimulated release of [³H]phosphatidylcholine. Inhibitory effects of $\text{48}\text{80}$ were noted following a 1 h exposure to compound $\text{48}\text{80}$ and persisted up to 3 h. The inhibitory effect of compound $\text{48}\text{80}$ was entirely reversed by removing compound $\text{48}\text{80}$ from the external milieu. Compound $\text{48}\text{80}$ had no effect on cytosolic cyclic AMP levels or lactate dehydrogenase release. Inhibition of surfactant release produced by compound $\text{48}\text{80}$ was unaffected by changes in extracellular calcium concentrations. Compound $\text{48}\text{80}$ is a non-toxic inhibitor of phosphatidylcholine release from Type II epithelial cells.     

Covalent modification of chloroplast Photosystem II polypeptides by p-nitrothiophenol

Illumination of the chlorophyll $\text{a}\text{b}$ light-harvesting complex in the presence of $\text{p-}\text{nitrothio}\text{[}{}^{14}\text{C]phenol}$ caused quenching of fluorescence emission at 685 nm (77 K) relative to 695 nm and covalent modification of light-harvesting complex polypeptides. Fluorescence quenching saturated with one p-nitrothiophenol bound per light-harvesting complex polypeptide (10–13 chlorophylls); $\text{1}\text{2}$ maximal quenching occurred with one p-nitrothiophenol bound per light-harvesting complex polypeptides (190–247 chlorophylls). This result provides direct evidence for excitation energy transfer between light-harvesting complex subunits which contain 4–6 polypeptides plus 40–78 chlorophylls per complex.Illumination of chloroplasts or Photosystem II (PS II) particles in the presence of $\text{p-}\text{nitrothio}\text{[}{}^{14}\text{C]phenol}$ caused inhibition of PS II activity and labeling of several polypeptides including those of 42–48 kilodaltons previously identified as PS II reaction center polypeptides. In chloroplasts, inhibition of oxygen evolution accelerated p-nitrothiophenol modification reactions; DCMU or donors to PS II decreased p-nitrothiophenol modification. These results are consistent with the hypothesis that accumulation of oxidizing equivalents on the donor side of PS II creates a ‘reactive state’ in which polypeptides of PS II are susceptible to p-nitrothiophenol modification.